Education
About Us
Working with TipRanks
Follow Us
Talkspace (TALK)
NASDAQ:TALK
TALK Stock Chart & Stats
$5.14
-$0.06(-1.90%)
At close: 4:00 PM EST
$5.14
-$0.06(-1.90%)
Day’s Range― - ―
52-Week Range$2.22 - $5.19
Previous CloseN/A
Volume269.09K
Average Volume (3M)5.33M
Market Cap
$858.77M
Enterprise Value$821.42M
Total Cash (Recent Filing)$92.59M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)78.5
Beta1.20
Next Earnings
May 05, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding167,076,000
10 Day Avg. Volume12,570,547
30 Day Avg. Volume5,327,286
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)5.22
Price to Sales (P/S)2.67
P/FCF Ratio-290.17
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue3.59
Enterprise Value/Gross Profit8.35
Enterprise Value/Ebitda69.08
Forecast
1Y Price Target
$5.92Price Target Upside15.18% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)0.14
Revenue Forecast (FY)$282.80M
Bulls Say, Bears Say
Bulls Say
Acquisition Strategic FitAnalyst says the acquisition diversifies revenue and gives the buyer immediate national-scale virtual care capabilities by integrating Talkspace's network of licensed clinicians, supporting an outpatient growth strategy.
Insurance Integrations And UtilizationAnalyst highlights that deeper integrations with payor portals and directory rollouts reduce sign-up friction, increase session bookings and utilization among insured patients, and can drive sustained revenue growth.
Product And AI-driven UpsideAnalyst points to a planned health privacy-compliant, clinician-reviewed large language model and TalkAI subscription plans as potential new recurring revenue streams and a direct-to-consumer growth channel that could add upside beyond current estimates.
Bears Say
Deal Valuation And Upside ConstraintAnalyst notes the acquisition price was below prior valuation expectations and largely prices in strategic value, limiting upside for shareholders and reducing the appeal of the stock as a standalone investment.
Market And Execution RisksAnalyst warns that weak consumer demand, rising customer acquisition costs, potential regulatory and reimbursement changes for behavioral telehealth, and increased spending on a proprietary large language model could pressure growth and cash generation.
Shareholder Return PolicyAnalyst flags the halt in share repurchases as a negative signal for shareholder return policy and a removal of buyback support that previously supported the stock.
Talkspace News
TALK FAQ
What was Talkspace’s price range in the past 12 months?
Talkspace lowest stock price was $2.22 and its highest was $5.19 in the past 12 months.
What is Talkspace’s market cap?
Talkspace’s market cap is $858.77M.
When is Talkspace’s upcoming earnings report date?
Talkspace’s upcoming earnings report date is May 05, 2026 which is in 42 days.
How were Talkspace’s earnings last quarter?
Talkspace released its earnings results on Feb 19, 2026. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of $0.021 by $0.009.
Is Talkspace overvalued?
According to Wall Street analysts Talkspace’s price is currently Undervalued.
Does Talkspace pay dividends?
Talkspace does not currently pay dividends.
What is Talkspace’s EPS estimate?
Talkspace’s EPS estimate is 0.02.
How many shares outstanding does Talkspace have?
Talkspace has 167,076,000 shares outstanding.
What happened to Talkspace’s price movement after its last earnings report?
Talkspace reported an EPS of $0.03 in its last earnings report, beating expectations of $0.021. Following the earnings report the stock price went up 22.901%.
Which hedge fund is a major shareholder of Talkspace?
Currently, no hedge funds are holding shares in TALK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Talkspace Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.92 (15.18% Upside)
$5.92 (15.18% Upside)
Blogger Sentiment
Bullish
TALK Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.2%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.55%
12-Months-Change
Fundamentals
Return on Equity
6.89%
Trailing 12-Months
Asset Growth
-36.63%
Trailing 12-Months
Company Description
Talkspace
Talkspace, Inc. operates as a virtual behavior healthcare company. It delivers healthcare through encrypted web and mobile platform. The company offers treatment options for every need, including psychiatry or adolescent, individual, or couples therapy. The members can send text, video, and voice messages to their therapists and engage in live video sessions. Talkspace, Inc. is based in New York, New York.
TALK Company Deck
TALK Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents strong top-line growth, accelerated Payor traction, significant adjusted EBITDA expansion and operational improvements, supported by product innovation (AI, Talkcast, psychiatry expansion) and M&A (Wisdo). There are manageable execution risks: near-term gross margin pressure from mix, reduced cash after buybacks and acquisition, deliberate de-emphasis of Consumer revenue, and uncertainty around TalkAI commercialization and Medicare penetration. Overall, the positives — recurring Payor growth, margin expansion, and confident 2026 guidance — materially outweigh the listed challenges.View all TALK earnings summariesTALK Stock 12 Month Forecast
Average Price Target
$5.92
▲(15.18% Upside)
Technical Analysis
Acadia Healthcare
―
Cross Country Healthcare
―
Pediatrix Medical Group
―
COMPASS Pathways
―
Lifestance Health Group
―
Ownership Overview
18.64% Insiders
18.14% Mutual Funds
26.02% Other Institutional Investors
27.92% Public Companies and
Individual Investors